GlassScriptPhysician profile
Stephen P Daane
NPI 1376644955
$413.16
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.42 · 2020: $102 · 2021: $69.08 · 2022: $173.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $173.30 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $52.32 | 2020 | |
| Genentech USA, INC. | $48.33 | 2019 | |
| Genzyme Corporation | $41.92 | 2021 | |
| Medela LLC | $28.11 | 2020 | |
| Organogenesis INC. | $27.16 | 2021 | |
| Dermira, INC. | $21.93 | 2020 | |
| Abbvie INC. | $20.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Daane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.